298 related articles for article (PubMed ID: 23430613)
1. Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention.
Wanschel A; Seibert T; Hewing B; Ramkhelawon B; Ray TD; van Gils JM; Rayner KJ; Feig JE; O'Brien ER; Fisher EA; Moore KJ
Arterioscler Thromb Vasc Biol; 2013 May; 33(5):886-93. PubMed ID: 23430613
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin-3E attenuates neointimal formation via suppressing VSMCs migration and proliferation.
Wu JH; Li Y; Zhou YF; Haslam J; Elvis ON; Mao L; Xia YP; Hu B
Cardiovasc Res; 2017 Dec; 113(14):1763-1775. PubMed ID: 29016743
[TBL] [Abstract][Full Text] [Related]
3. A class III semaphorin (Sema3e) inhibits mouse osteoblast migration and decreases osteoclast formation in vitro.
Hughes A; Kleine-Albers J; Helfrich MH; Ralston SH; Rogers MJ
Calcif Tissue Int; 2012 Feb; 90(2):151-62. PubMed ID: 22227882
[TBL] [Abstract][Full Text] [Related]
4. Plexin D1 negatively regulates macrophage-derived foam cell migration via the focal adhesion kinase/Paxillin pathway.
Li C; Niu Y; Chen J; Geng S; Wu P; Dai L; Dong C; Liu R; Shi Y; Wang X; Gao Z; Liu X; Yang X; Gao S
Biochem Biophys Res Commun; 2024 Sep; 725():150236. PubMed ID: 38897039
[TBL] [Abstract][Full Text] [Related]
5. The macrophage C-type lectin receptor CLEC5A (MDL-1) expression is associated with early plaque progression and promotes macrophage survival.
Xiong W; Wang H; Lu L; Xi R; Wang F; Gu G; Tao R
J Transl Med; 2017 Nov; 15(1):234. PubMed ID: 29126450
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin 3E Regulates the Response of Macrophages to Lipopolysaccharide-Induced Systemic Inflammation.
Mohammed A; Okwor I; Shan L; Onyilagha C; Uzonna JE; Gounni AS
J Immunol; 2020 Jan; 204(1):128-136. PubMed ID: 31776203
[TBL] [Abstract][Full Text] [Related]
7. The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques.
van Gils JM; Derby MC; Fernandes LR; Ramkhelawon B; Ray TD; Rayner KJ; Parathath S; Distel E; Feig JL; Alvarez-Leite JI; Rayner AJ; McDonald TO; O'Brien KD; Stuart LM; Fisher EA; Lacy-Hulbert A; Moore KJ
Nat Immunol; 2012 Jan; 13(2):136-43. PubMed ID: 22231519
[TBL] [Abstract][Full Text] [Related]
8. Silencing Myeloid Netrin-1 Induces Inflammation Resolution and Plaque Regression.
Schlegel M; Sharma M; Brown EJ; Newman AAC; Cyr Y; Afonso MS; Corr EM; Koelwyn GJ; van Solingen C; Guzman J; Farhat R; Nikain CA; Shanley LC; Peled D; Schmidt AM; Fisher EA; Moore KJ
Circ Res; 2021 Aug; 129(5):530-546. PubMed ID: 34289717
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin 3d and semaphorin 3e direct endothelial motility through distinct molecular signaling pathways.
Aghajanian H; Choi C; Ho VC; Gupta M; Singh MK; Epstein JA
J Biol Chem; 2014 Jun; 289(26):17971-9. PubMed ID: 24825896
[TBL] [Abstract][Full Text] [Related]
10. Neuronal chemorepellent Semaphorin 3E inhibits human airway smooth muscle cell proliferation and migration.
Movassagh H; Shan L; Halayko AJ; Roth M; Tamm M; Chakir J; Gounni AS
J Allergy Clin Immunol; 2014 Feb; 133(2):560-7. PubMed ID: 23932461
[TBL] [Abstract][Full Text] [Related]
11. Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development.
Chauvet S; Cohen S; Yoshida Y; Fekrane L; Livet J; Gayet O; Segu L; Buhot MC; Jessell TM; Henderson CE; Mann F
Neuron; 2007 Dec; 56(5):807-22. PubMed ID: 18054858
[TBL] [Abstract][Full Text] [Related]
12. Resolution of defective dorsal aortae patterning in Sema3E-deficient mice occurs via angiogenic remodeling.
Meadows SM; Ratliff LA; Singh MK; Epstein JA; Cleaver O
Dev Dyn; 2013 May; 242(5):580-90. PubMed ID: 23444297
[TBL] [Abstract][Full Text] [Related]
13. Chemorepellent Semaphorin 3E Negatively Regulates Neutrophil Migration In Vitro and In Vivo.
Movassagh H; Saati A; Nandagopal S; Mohammed A; Tatari N; Shan L; Duke-Cohan JS; Fowke KR; Lin F; Gounni AS
J Immunol; 2017 Feb; 198(3):1023-1033. PubMed ID: 27913633
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis.
Moriya J; Minamino T; Tateno K; Okada S; Uemura A; Shimizu I; Yokoyama M; Nojima A; Okada M; Koga H; Komuro I
Circ Res; 2010 Feb; 106(2):391-8. PubMed ID: 19940264
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques: mechanism for macrophage retention and survival.
Ramkhelawon B; Yang Y; van Gils JM; Hewing B; Rayner KJ; Parathath S; Guo L; Oldebeken S; Feig JL; Fisher EA; Moore KJ
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1180-8. PubMed ID: 23599441
[TBL] [Abstract][Full Text] [Related]
16. Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression.
Potteaux S; Gautier EL; Hutchison SB; van Rooijen N; Rader DJ; Thomas MJ; Sorci-Thomas MG; Randolph GJ
J Clin Invest; 2011 May; 121(5):2025-36. PubMed ID: 21505265
[TBL] [Abstract][Full Text] [Related]
17. The role of macrophage transcription factor MafB in atherosclerotic plaque stability.
Hasegawa H; Watanabe T; Kato S; Toshima T; Yokoyama M; Aida Y; Nishiwaki M; Kadowaki S; Narumi T; Honda Y; Otaki Y; Honda S; Shunsuke N; Funayama A; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Abe S; Shibata Y; Kubota I
Atherosclerosis; 2016 Jul; 250():133-43. PubMed ID: 27214395
[TBL] [Abstract][Full Text] [Related]
18. Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice.
Fukushima Y; Okada M; Kataoka H; Hirashima M; Yoshida Y; Mann F; Gomi F; Nishida K; Nishikawa S; Uemura A
J Clin Invest; 2011 May; 121(5):1974-85. PubMed ID: 21505259
[TBL] [Abstract][Full Text] [Related]
19. Binding and complementary expression patterns of semaphorin 3E and plexin D1 in the mature neocortices of mice and monkeys.
Watakabe A; Ohsawa S; Hashikawa T; Yamamori T
J Comp Neurol; 2006 Nov; 499(2):258-73. PubMed ID: 16977617
[TBL] [Abstract][Full Text] [Related]
20. Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy.
Momtazi-Borojeni AA; Abdollahi E; Nikfar B; Chaichian S; Ekhlasi-Hundrieser M
Heart Fail Rev; 2019 May; 24(3):399-409. PubMed ID: 30673930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
